2 Information about ritlecitinib

Marketing authorisation indication


Ritlecitinib (Litfulo, Pfizer) is indicated for 'the treatment of severe alopecia areata in adults and adolescents 12 years of age and older'.

Dosage in the marketing authorisation



Ritlecitinib costs £949.41 per pack of 30 capsules (dictionary of medicines and devices, accessed February 2024).


The company has a commercial arrangement. This makes ritlecitinib available to the NHS with a discount. The size of the discount is commercial in confidence. It is the company's responsibility to let relevant NHS organisations know details of the discount.

  • National Institute for Health and Care Excellence (NICE)